ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Jul 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
August 2025
Nuclear Technology
Fusion Science and Technology
July 2025
Latest News
Hash Hashemian: Visionary leadership
As Dr. Hashem M. “Hash” Hashemian prepares to step into his term as President of the American Nuclear Society, he is clear that he wants to make the most of this unique moment.
A groundswell in public approval of nuclear is finding a home in growing governmental support that is backed by a tailwind of technological innovation. “Now is a good time to be in nuclear,” Hashemian said, as he explained the criticality of this moment and what he hoped to accomplish as president.
Bradley K. Heath, Cody C. Race
Nuclear Technology | Volume 205 | Number 10 | October 2019 | Pages 1369-1377
Technical Note | doi.org/10.1080/00295450.2019.1589853
Articles are hosted by Taylor and Francis Online.
The Resumption of Transient Testing Program was created to re-establish transient testing capability in the United States, specifically at the Transient Reactor Test (TREAT) Facility, located at the Idaho National Laboratory. The restart of TREAT began in early 2014 and concluded in August of 2017. The restart of TREAT occurred 13 months ahead of schedule and $20 million below the $75 million original budget. High-level detail of the restart effort along with several significant factors that contributed to successful restart of TREAT are discussed.
